{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:59:55Z","timestamp":1781812795789,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFA0103700"],"award-info":[{"award-number":["2017YFA0103700"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of Zhejiang Province","award":["31571528"],"award-info":[{"award-number":["31571528"]}]},{"name":"National Natural Science Foundation of Zhejiang Province","award":["LR15H020001"],"award-info":[{"award-number":["LR15H020001"]}]},{"name":"Recruitment Program of Global Experts of the Organization Department of the Central Committee of the CPC"},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.yjmcc.2018.10.020","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T11:32:00Z","timestamp":1541849520000},"page":"143-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Inhibition of TRPC1 prevents cardiac hypertrophy via NF-\u03baB signaling pathway in human pluripotent stem cell-derived cardiomyocytes"],"prefix":"10.1016","volume":"126","author":[{"given":"Ling","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.10.020_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jash.2011.08.006","article-title":"Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives","volume":"5","author":"Cacciapuoti","year":"2011","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/CIRCEP.112.977777","article-title":"Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy","volume":"6","author":"Okin","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjcard.2014.07.015","article-title":"Meta-analysis of left ventricular hypertrophy and sustained arrhythmias","volume":"114","author":"Chatterjee","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/FJC.0000000000000126","article-title":"Targeting cardiac hypertrophy: toward a causal heart failure therapy","volume":"64","author":"Bisping","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0035","first-page":"3217","article-title":"Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK\/STAT pathway","volume":"9","author":"Al-Rasheed","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.113.008268","article-title":"Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine","volume":"66","author":"Nilius","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00424-010-0847-8","article-title":"Canonical TRP channels and mechanotransduction: from physiology to disease states","volume":"460","author":"Patel","year":"2010","journal-title":"Pflugers Archiv. Eur. J. Physiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ceca.2005.06.028","article-title":"TRP channels: an overview","volume":"38","author":"Pedersen","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0055","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1073\/pnas.92.21.9652","article-title":"TRPC1, a human homolog of a Drosophila store-operated channel","volume":"92","author":"Wes","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-5793(95)01038-G","article-title":"Molecular cloning of a widely expressed human homologue for the Drosophila trp gene","volume":"373","author":"Zhu","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000233356.10630.8a","article-title":"Transient receptor potential channels in cardiovascular function and disease","volume":"99","author":"Inoue","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbadis.2007.02.007","article-title":"Involvement of transient receptor potential proteins in cardiac hypertrophy","volume":"1772","author":"Guinamard","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00395-017-0643-0","article-title":"Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs","volume":"112","author":"Li","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0080","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.carpath.2016.08.004","article-title":"Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure","volume":"25","author":"Morine","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0085","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.1001825107","article-title":"TRPC channels are necessary mediators of pathologic cardiac hypertrophy","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yjmcc.2006.10.020","article-title":"Upregulation of TRPC1 in the development of cardiac hypertrophy","volume":"42","author":"Ohba","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1159\/000354498","article-title":"Upregulation of TRPC1 contributes to contractile function in isoproterenol-induced hypertrophic myocardium of rat","volume":"32","author":"Chen","year":"2013","journal-title":"Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbrc.2013.06.002","article-title":"Sildenafil prevents the up-regulation of transient receptor potential canonical channels in the development of cardiomyocyte hypertrophy","volume":"436","author":"Kiso","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.109.206581","article-title":"TRPC1 channels are critical for hypertrophic signaling in the heart","volume":"105","author":"Seth","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0110","doi-asserted-by":"crossref","first-page":"512831","DOI":"10.1155\/2014\/512831","article-title":"Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools","volume":"2014","author":"Acimovic","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/scrt308","article-title":"Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives","volume":"4","author":"Chow","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12265-012-9423-2","article-title":"A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards","volume":"6","author":"Mordwinkin","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2018.10.020_bb0125","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","article-title":"Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy applications: Progress and Hurdles for Clinical translation","volume":"26","author":"Oikonomopoulos","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0135","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jmoldx.2014.05.002","article-title":"Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes","volume":"16","author":"Liang","year":"2014","journal-title":"J. Mol. Diagnost."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/pd.4033","article-title":"Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing","volume":"33","author":"Liang","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0155","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0160","doi-asserted-by":"crossref","first-page":"H2777","DOI":"10.1152\/ajpheart.00171.2004","article-title":"Protein kinase C-alpha-induced hypertrophy of neonatal rat ventricular myocytes","volume":"287","author":"Vijayan","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.200108062","article-title":"PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1\/2 (ERK1\/2)","volume":"156","author":"Braz","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0170","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","article-title":"Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5","volume":"24","author":"Vega","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0180","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1083\/jcb.200207149","article-title":"Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy","volume":"159","author":"Gupta","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0190","doi-asserted-by":"crossref","first-page":"H1712","DOI":"10.1152\/ajpheart.00124.2004","article-title":"NF-kappaB activation is required for the development of cardiac hypertrophy in vivo","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0195","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0200","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-kappaB activation is required for adaptive cardiac hypertrophy","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0205","doi-asserted-by":"crossref","first-page":"H962","DOI":"10.1152\/ajpheart.2001.280.3.H962","article-title":"Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction","volume":"280","author":"Haudek","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.10.020_bb0210","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000108929.93074.0B","article-title":"Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction","volume":"108","author":"Misra","year":"2003","journal-title":"Circulation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818303560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818303560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:44:27Z","timestamp":1565261067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818303560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":42,"alternative-id":["S0022282818303560"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.020","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TRPC1 prevents cardiac hypertrophy via NF-\u03baB signaling pathway in human pluripotent stem cell-derived cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}